ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 2 analysts with an average price target of $56.69. This is a potential upside of $50.19 (772.15%) from yesterday's end of day stock price of $6.5.

Atara Biotherapeutics's activity chart (see below) currently has 87 price targets and 88 ratings on display. The stock rating distribution of ATRA is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.58% with an average time for these price targets to be met of 93.1 days.

Highest price target for ATRA is $18, Lowest price target is $6, average price target is $12.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 13-Jan-2026. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Jan-2026

$6

$-0.5 (-7.69%)

$25

2 months 1 days ago
(13-Jan-2026)

5/8 (62.5%)

$1.63 (37.30%)

156

Buy Since 16-Aug-2024

$18

$11.5 (176.92%)

$16

3 months 21 days ago
(21-Nov-2025)

2/6 (33.33%)

$4.32 (31.58%)

37

Hold Since 09-Nov-2023

1 years 1 months 14 days ago
(28-Jan-2025)

1/4 (25%)

$376.5 (88.90%)

175

Hold Since 13-Jul-2022

$5

$-1.5 (-23.08%)

$10

1 years 1 months 21 days ago
(21-Jan-2025)

3/8 (37.5%)

$-1.05 (-17.36%)

141

Sell Since 21-Aug-2023

$35

$28.5 (438.46%)

$75

2 years 6 months 21 days ago
(21-Aug-2023)

13/13 (100%)

$-0.25 (-0.71%)

298

Show more analysts

Please expand the browser size to see the chart

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 93.1 days on average for the stock forecasts to be realized with a an average price target met ratio 44.58

Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?

MAURY RAYCROFT

Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

Maury Raycroft works at JEFFERIES and has 3 price targets and 2 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with highest potential upside - $618.5

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

Benjamin Burnett with lowest potential downside - -$1.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?